Pezzella F, Morrison H, Jones M, Gatter K C, Lane D, Harris A L, Mason D Y
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford, UK.
Histopathology. 1993 Jan;22(1):39-44. doi: 10.1111/j.1365-2559.1993.tb00067.x.
We have investigated the immunohistochemical expression of p53 protein in 96 cases of non-Hodgkin's lymphoma using a panel of five antibodies. Positive neoplastic cells were found in 30 (31.2%) cases, which could be divided into two groups according to their patterns of reactivity with the different antibodies; i.e. those positive with both polyclonal and monoclonal antibodies, and those which were stained only by monoclonal antibodies PAb1801 and/or PAb240. Positivity was nuclear in all but six cases in which cytoplasmic staining was found. In view of the hypothesis recently raised that p53 protein induces apoptosis we have compared our results with parallel staining for bcl-2 protein since bcl-2 is believed to be important, at least in lymphomas, in suppression of apoptosis. Staining for bcl-2 protein was performed on 83 cases and it was shown that p53-positive cases accounted for 10 out of 17 (59%) of the bcl-2-negative lymphomas but only for 15 out of the 66 (23%) bcl-2-positive cases, suggesting a possible relationship between the expression of these two proteins. Thus, our data show that p53 protein is abnormally expressed in a substantial proportion of non-Hodgkin's lymphomas and bears a significant inverse relationship to bcl-2 protein expression. However the molecular basis of this expression remains to be elucidated.
我们使用一组五种抗体,对96例非霍奇金淋巴瘤患者p53蛋白的免疫组化表达情况进行了研究。在30例(31.2%)病例中发现了阳性肿瘤细胞,根据其与不同抗体的反应模式可分为两组,即对多克隆和单克隆抗体均呈阳性的细胞,以及仅被单克隆抗体PAb1801和/或PAb240染色的细胞。除6例发现胞质染色的病例外,其余所有阳性病例的染色均位于细胞核。鉴于最近提出的p53蛋白诱导细胞凋亡的假说,我们将我们的结果与bcl-2蛋白的平行染色结果进行了比较,因为至少在淋巴瘤中,bcl-2被认为在抑制细胞凋亡方面很重要。对83例病例进行了bcl-2蛋白染色,结果显示,在17例bcl-2阴性淋巴瘤中,p53阳性病例占10例(59%),而在66例bcl-2阳性病例中仅占15例(23%),这表明这两种蛋白的表达之间可能存在关联。因此,我们的数据表明,p53蛋白在相当一部分非霍奇金淋巴瘤中异常表达,且与bcl-2蛋白表达呈显著负相关。然而,这种表达的分子基础仍有待阐明。